Rice Hall James & Associates, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$35.41 - $44.37 $118,800 - $148,861	3,355 Added 3.74%	93,081 $3.82 Million
Q1 2024 Apr 23, 2024	BUY	$39.12 - $52.44 $4,733 - $6,345	121 Added 0.14%	89,726 $3.89 Million
Q4 2023 Feb 08, 2024	SELL	$21.39 - $49.64 $1.45 Million - $3.37 Million	-67,821 Reduced 43.08%	89,605 $4.12 Million
Q3 2023 Nov 02, 2023	SELL	$15.81 - $27.8 $24,236 - $42,617	-1,533 Reduced 0.96%	157,426 $3.61 Million
Q2 2023 Jul 24, 2023	BUY	$16.32 - $21.15 $84,423 - $109,408	5,173 Added 3.36%	158,959 $2.62 Million
Q1 2023 May 11, 2023	BUY	$16.88 - $34.24 $9,857 - $19,996	584 Added 0.38%	153,786 $2.74 Million
Q4 2022 Jan 27, 2023	SELL	$22.21 - $30.25 $381,012 - $518,938	-17,155 Reduced 10.07%	153,202 $0
Q3 2022 Nov 01, 2022	BUY	$4.3 - $30.85 $48,835 - $350,363	11,357 Added 7.14%	170,357 $4.17 Million
Q2 2022 Aug 08, 2022	BUY	$3.12 - $12.25 $70,134 - $275,367	22,479 Added 16.47%	159,000 $660,000
Q1 2022 May 05, 2022	BUY	$6.13 - $12.24 $55,016 - $109,854	8,975 Added 7.04%	136,521 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $191,139 - $308,218	-22,174 Reduced 14.81%	127,546 $1.27 Million
Q3 2021 Nov 09, 2021	BUY	$11.68 - $20.72 $66,879 - $118,642	5,726 Added 3.98%	149,720 $1.96 Million
Q2 2021 Jul 29, 2021	BUY	$18.52 - $22.55 $1.48 Million - $1.8 Million	79,733 Added 124.08%	143,994 $2.82 Million
Q1 2021 May 14, 2021	BUY	$20.25 - $39.49 $314,644 - $613,595	15,538 Added 31.89%	64,261 $1.37 Million
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $124,225 - $191,355	-5,868 Reduced 10.75%	48,723 $1.45 Million
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $315,117 - $532,032	17,381 Added 46.71%	54,591 $1.18 Million
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $355,984 - $626,246	-24,704 Reduced 39.9%	37,210 $830,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $8,146 - $14,175	619 Added 1.01%	61,914 $942,000
Q4 2019 Jan 29, 2020	SELL	$19.53 - $25.5 $68,530 - $89,479	-3,509 Reduced 5.41%	61,295 $1.41 Million
Q3 2019 Oct 30, 2019	BUY	$18.62 - $24.51 $29,549 - $38,897	1,587 Added 2.51%	64,804 $1.4 Million
Q2 2019 Aug 01, 2019	BUY	$21.11 - $28.48 $844,716 - $1.14 Million	40,015 Added 172.46%	63,217 $1.39 Million
Q1 2019 May 01, 2019	BUY	$24.76 - $31.66 $574,481 - $734,575	23,202 New	23,202 $636,000

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$406 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$379 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$360 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$342 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$218 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account